HL
Harding Loevner’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-767
| Closed | -$81K | – | 133 |
|
|
2022
Q3 | $81K | Sell |
767
-43
| -5% | -$4.54K | ﹤0.01% | 90 |
|
|
2022
Q2 | $79K | Hold |
810
| – | – | ﹤0.01% | 90 |
|
|
2022
Q1 | $61K | Buy |
810
+33
| +4% | +$2.49K | ﹤0.01% | 95 |
|
|
2021
Q4 | $66K | Buy |
777
+215
| +38% | +$18.3K | ﹤0.01% | 102 |
|
|
2021
Q3 | $54K | Hold |
562
| – | – | ﹤0.01% | 99 |
|
|
2021
Q2 | $55K | Hold |
562
| – | – | ﹤0.01% | 105 |
|
|
2021
Q1 | $55K | Hold |
562
| – | – | ﹤0.01% | 110 |
|
|
2020
Q4 | $54K | Hold |
562
| – | – | ﹤0.01% | 106 |
|
|
2020
Q3 | $54K | Buy |
562
+306
| +120% | +$29.4K | ﹤0.01% | 137 |
|
|
2020
Q2 | $31K | Hold |
256
| – | – | ﹤0.01% | 117 |
|
|
2020
Q1 | $22K | Buy |
+256
| New | +$22K | ﹤0.01% | 121 |
|